TANNQUILYNNE

Welcome to the Brand page for “TANNQUILYNNE”, which is offered here for Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; phenol for pharmaceutical purposes; plant extracts for medical, veterinary and pharmaceutical purposes; syrups for pharmaceutical purposes for the treatment of dementia; chemical preparations for pharmaceutical or medical purposes, for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; plant extracts for pharmaceutical purposes; pharmaceutical preparations for treating sunburn; chemical reagents for medical or veterinary purposes; adjuvants for medical purposes; animal feed additive for use as a nutritional supplement for medical purposes; medicinal herbal extracts for medical purposes; antibacterial substances for medical purposes; transdermal patches featuring medication for the treatment of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; herbal extracts for medical purposes; phytotherapy preparations for medical purposes; appetite suppressants for medical purposes; beverages containing tannic acid for use as a nutritional supplement; liquid nutritional supplement; dietary and nutritional supplements; nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; powdered nutritional supplement drink mix; nutritional supplement meal replacement bars for boosting energy; nutritional supplements consisting primarily of tannic acid; dietary and nutritional supplements used for weight loss; nutritional supplement shakes; nutritional and dietary supplements formed and packaged as bars; nutritional supplements in capsule form for dogs; nutritional supplements; nutritional supplement for eliminating toxins from the body; nutritionally fortified water for medical purposes; nutritionally fortified beverages for medical purposes; vitamin fortified beverages for medical purposes; vitamin enriched chewing gum for medical purposes; soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; powdered nutritional supplement drink mix containing tannic acid; nutritional supplements for cats, dogs; nutraceuticals for use as a dietary supplement for cognitive impairment; nutraceuticals for the treatment of cns disorders; nutraceuticals for use as a dietary supplement;.

Its status is currently believed to be active. Its class is unavailable. “TANNQUILYNNE” is believed to be currently owned by “SyneuRx International (Taiwan) Corp.”